If heart disease runs in your family, you have probably been told two things that pull in opposite directions. The first is that your risk is partly written in your genes, and there is nothing you can do about that. The second is that you should exercise anyway. The unspoken question underneath is whether the second thing actually helps people in the grip of the first — or whether walking is just something the lucky do to stay lucky. A study published on 9 June in the European Journal of Preventive Cardiology answers it about as cleanly as observational science can [1]. A team at the University of Oxford followed 84,286 adults, wearing motion trackers on their wrists, for a median of nearly eight years, and asked whether daily steps lowered heart-disease risk independently of inherited risk. The answer was yes — and the size of the effect is the part worth sitting with.
What the Oxford team did
Every participant came from UK Biobank, the large British research cohort, and had two things on file: a week of accelerometer data establishing their typical daily step count, and a genetic risk score for cardiovascular disease. The researchers sorted people into low, moderate, and high genetic risk, and into low (under 6,500 steps a day), moderate, and high (12,500 or more) step counts. Then they tracked who went on to develop cardiovascular disease — defined as coronary artery disease or ischaemic stroke — over the follow-up years. Of the 84,286 adults, 4,847 did.
The comparison that matters is between the two corners of that grid. Take the people who drew the best hand and played it well: low genetic risk and a high step count. Their absolute risk of cardiovascular disease over the study was 62 per 1,000. Now take the opposite corner — high genetic risk and a low step count. Their risk was 174 per 1,000, a hazard ratio of 2.81 against the reference group [1]. Nearly three times as high. That is the spread between the two extremes, and it is wide enough that no one should mistake either genes or walking for a rounding error.
The number inside the number
The headline contrast is striking, but the genuinely useful finding is quieter and sits in the statistics. The researchers tested whether genes and steps interact — whether walking helps the genetically lucky more than the genetically loaded, or vice versa. They found no such interaction (the test came back at p = 0.46). In plain terms: walking lowered risk by about the same amount whether you were born with low inherited risk or high. The benefit of steps did not depend on the genes you were dealt.
This is the opposite of fatalism. A high family-history risk is sometimes read as a reason to give up — if the deck is stacked, why bother? The data says the deck being stacked is precisely why bothering pays. The authors put it directly: walking should be encouraged for everyone, and especially for those predisposed to heart disease, because they have the most absolute risk to claw back. The dose-response curve told the same story from another angle. Risk fell steadily as step counts rose, up to around 10,000 steps a day, where the benefit began to level off — and the steepest part of that curve, the part where each extra bit of walking bought the most protection, was down at the low end, among the people doing the least.
Walking lowered heart risk by the same amount whether you were born lucky or loaded. A high inherited risk is not a reason to give up on the walk. It is the reason to take it.
From a wrist tracker to your own two feet
An observational study cannot prove that taking up walking will lower one particular person’s risk by a calculable amount; it shows a strong, dose-dependent association across tens of thousands of people, adjusted for the obvious confounders. But the direction is not in doubt, and it lines up with everything the interventional literature already shows about what structured walking does to a cardiovascular system. The Shinshu University interval-walking trial — 246 middle-aged and older adults, five months — reported a nine-millimetre drop in systolic blood pressure and a nine per cent gain in peak aerobic walking capacity in the interval group, against a steady-pace comparison [2]. Blood pressure and aerobic capacity are two of the main roads through which more walking becomes less heart disease. The Oxford study counts the steps; the Shinshu trial shows what happens to the body when those steps are paced with intent rather than ambled through.
The practical reading is short. If your family history worries you, that worry is well founded — and it is also the strongest argument anyone could hand you for the walk you keep meaning to start. The step count is the one line on your cardiovascular risk chart that you fully control. You cannot choose the genes. You can choose, most days, to move your number up the curve.
